Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNU6-360P** (RNA, U6 small nuclear 360, pseudogene) is a *pseudogene* corresponding to the U6 small nuclear RNA gene. U6 small nuclear RNA itself is a highly conserved, functional, noncoding RNA and a key catalytic component of the spliceosome, which is the molecular complex responsible for excising introns from pre-messenger RNA in eukaryotic cells[1][3]. However, **pseudogenes** like RNU6-360P are non-functional genomic sequences that resemble functional snRNA genes but have lost their ability to encode functional RNA or protein due to mutations or truncations[2][5][6]. U6 snRNA pseudogenes are generally the result of retrotransposition events—often mediated by LINE-1 (L1) elements—which duplicate snRNA genes and insert inactive copies into the genome[5][6]. These pseudogenes do not participate in splicing, are not known to be involved in disease, do not code for any protein or functional RNA, and are not considered therapeutic targets or biomarkers. Their main value is as genomic markers for retrotransposition activity and genome evolution research[6]. **Note:** The designation "pseudogene" in the name RNU6-360P means it is not a functional gene product or a therapeutic target, and there is no evidence for disease association, drug targeting, or known biological function for this specific molecule. There is nothing therapeutically actionable about this entry; its main relevance is for genomic annotation and retrotransposition studies[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 360, pseudogene (RNU6-360P).